Breckenridge Pharmaceutical today announced a voluntary recall of one lot of 60mg Propranolol Hydrochloride Extended‑Release Capsules after testing revealed metal fragments that could cause internal lacerations.
The affected 100‑count bottles, lot PK25110035, expire May 2029, and carry NDC 51991‑817‑01, were shipped to wholesalers and pharmacies nationwide from Oct. 26 to Nov. 4.
“Use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine,” the company said in a press release.
Breckenridge confirmed it has not received any adverse event reports linked to the recall.
Consumers who have the product should stop taking it immediately, contact their healthcare provider, and report any symptoms to the FDA’s MedWatch program.
MORE THAN 720K BMW VEHICLES RECALLED OVER FIRE THREAT, REGULATORS SAY
Regulators have ordered a recall of more than 720,000 BMW vehicles because a fire‑risk defect may ignite the engine compartment.
THANKSGIVING STAPLE RECALLED AT COSTCO OVER POSSIBLE CONTAMINATION WITH CLEANING CHEMICAL
Costco is pulling a popular Thanksgiving side dish after detecting traces of a cleaning chemical that could pose health risks.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Breckenridge advised pharmacies and wholesalers to quarantine the recalled lot, cease distribution, and return any unused portions to the point of purchase.
Propranolol is commonly prescribed to treat high blood pressure, and it also addresses chest pain, migraines, and tremors.
